Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
As of May 2022 Novo Nordisk has a market cap of $244.30 Billion. This makes Novo Nordisk the world's 32th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $244.30 B | -4.22% |
2021 | $255.07 B | 56.42% |
2020 | $163.07 B | 17.22% |
2019 | $139.12 B | 24.43% |
2018 | $111.80 B | -14.74% |
2017 | $131.12 B | 39.24% |
2016 | $94.17 B | -38.17% |
2015 | $152.30 B | 35.23% |
2014 | $112.62 B | 11.3% |
2013 | $101.18 B | 11.24% |
2012 | $90.96 B | 36.37% |
2011 | $66.70 B | -1.24% |
2010 | $67.54 B | 66.85% |
2009 | $40.48 B | 24.25% |
2008 | $32.58 B | -22.36% |
2007 | $41.96 B | 58.17% |
2006 | $26.53 B | 45.63% |
2005 | $18.21 B | 1.1% |
2004 | $18.02 B | 27.41% |
2003 | $14.14 B | 40.56% |
2002 | $10.06 B | -27.62% |
2001 | $13.90 B |
On May 20th, 2022 the market cap of Novo Nordisk was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $294.40 B | 20.51% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $283.95 B | 16.23% | ๐บ๐ธ USA |
![]() Sanofi SNY | $135.85 B | -44.39% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $162.21 B | -33.60% | ๐บ๐ธ USA |